OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adoptive transfer of personalized neoantigen-reactive TCR-transduced T cells in metastatic colorectal cancer: phase 2 trial interim results
Maria R. Parkhurst, Stephanie L. Goff, Frank J. Lowery, et al.
Nature Medicine (2024) Vol. 30, Iss. 9, pp. 2586-2595
Open Access | Times Cited: 20

Showing 20 citing articles:

Neoantigen-specific tumor-infiltrating lymphocytes in gastrointestinal cancers: a phase 2 trial
Frank J. Lowery, Stephanie L. Goff, Billel Gasmi, et al.
Nature Medicine (2025)
Closed Access | Times Cited: 1

Cell-Based Therapies in GI Cancers: Current Landscape and Future Directions
Izuma Nakayama, Kohei Shitara
American Society of Clinical Oncology Educational Book (2025) Vol. 45, Iss. 1
Closed Access

Individualized Neoantigen-Directed Melanoma Therapy
Karam Khaddour, Elizabeth I. Buchbinder
American Journal of Clinical Dermatology (2025)
Closed Access

Defeating Cancer with Armed Antibodies and Genetically Modified Immune Cells
Liang Zhao
Highlights in Science Engineering and Technology (2025) Vol. 129, pp. 57-66
Closed Access

Liver Metastasis in Cancer: Molecular Mechanisms and Management
Wenchao Xu, Jia Xu, Jianzhou Liu, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access

T-cell receptors identified by a personalized antigen-agnostic screening approach target shared neoantigen KRAS Q61H
Volker Lennerz, Christoph Doppler, Martina Fatho, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access

Neue Ansätze in der Immuntherapie gastrointestinaler Tumoren
Bernd Heinrich, Tim F. Greten
Deleted Journal (2025)
Open Access

Selection of therapeutically effective T-cell receptors from the diverse tumor-bearing repertoire
Leonie Rosenberger, Leo Hansmann, Vasiliki Anastasopoulou, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 5, pp. e011351-e011351
Open Access

TCR3d 2.0: expanding the T cell receptor structure database with new structures, tools and interactions
Valerie C. L. Lin, Melyssa Cheung, Ragul Gowthaman, et al.
Nucleic Acids Research (2024) Vol. 53, Iss. D1, pp. D604-D608
Open Access | Times Cited: 3

T cells lead the charge against solid tumors
Rigel J. Kishton, Nicholas P. Restifo
Nature Cancer (2024)
Closed Access | Times Cited: 2

Genetically Engineered T Cells and Recombinant Antibodies to Target Intracellular Neoantigens: Current Status and Future Directions
Ana Maria Waaga-Gasser, Thomas Böldicke
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13504-13504
Open Access | Times Cited: 1

CD8α Structural Domains Enhance GUCY2C CAR-T Cell Efficacy
Trevor R. Baybutt, Ariana A. Entezari, Adi Caspi, et al.
Cancer Biology & Therapy (2024) Vol. 25, Iss. 1
Open Access

More T cell receptors to the RAScue in cancer?
Eric Tran
Journal of Clinical Investigation (2024) Vol. 134, Iss. 21
Open Access

Adoptive transfer of membrane-restricted IL-12-TCR T cells promotes antigen spreading and elimination of antigen-negative tumor variants
Ling Zhang, Scott M. Norberg, Farrah Karimipour, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 11, pp. e009868-e009868
Open Access

Spatio-temporal T cell tracking for personalized TCR-T designs in childhood cancer
Inés Sentís, Juan L. Melero, Alex Cebria‐Xart, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Genetic immune escape in cancer: timing and implications for treatment
Francisco Martínez-Jiménez, Diego Chowell
Trends in cancer (2024)
Closed Access

Clinical trials, challenges, and changes in TCR-based therapeutics for hematologic malignancies
Melinda A. Biernacki, Marie Bleakley
Expert Review of Hematology (2024), pp. 1-11
Closed Access

Page 1

Scroll to top